This text discusses the histone code and the importance of histone binding proteins as regulators of development and disease. It also highlights the need for small molecule probes to study these proteins and potentially discover new drug targets. The focus is on an AlphaScreen- based HTS assay for MBT domain-containing proteins, which bind to lower methylation states of lysine residues in histone tail peptides. Is the molecule effective to this assay?